Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokines in recurrent miscarriage.

H Carp1

  • 1Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Aviv, Israel. carp@netvision.net.il

Lupus
|October 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Indications--intravenous immunoglobulins--IVIG].

Harefuah·2005
Same author

Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study.

Journal of thrombosis and haemostasis : JTH·2005
Same author

Autoantibody panel screening in recurrent miscarriages.

American journal of reproductive immunology (New York, N.Y. : 1989)·2004
Same author

NQO2 gene is associated with clozapine-induced agranulocytosis.

Tissue antigens·2003
Same author

Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome.

Journal of thrombosis and haemostasis : JTH·2003
Same author

Treatment of pregnant patients with antiphospholipid syndrome.

Lupus·2003
Same journal

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research.

Lupus·2026
Same journal

T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus.

Lupus·2026
Same journal

Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis.

Lupus·2026
Same journal

Recent advances in the management of pediatric neuropsychiatric lupus from conventional therapies to novel immunomodulators.

Lupus·2026
Same journal

Association of serum and urinary galectin-3 with renal fibrosis in patients with lupus nephritis: A cross-sectional controlled study.

Lupus·2026
Same journal

Continuation of belimumab in patients with systemic lupus erythematosus in a real-world setting: A single-center retrospective cohort study.

Lupus·2026
See all related articles

Cytokines influence pregnancy from implantation to birth, playing a role in recurrent miscarriage. Their balance is crucial, as dysregulation can lead to pregnancy loss, but therapies are still under investigation.

Area of Science:

  • Reproductive Immunology
  • Obstetrics and Gynecology

Background:

  • Cytokines are critical immune mediators involved throughout pregnancy, influencing key events from implantation to parturition.
  • Recurrent miscarriage (RM) can stem from embryonic chromosomal abnormalities or maternal factors like uterine anomalies and antiphospholipid antibodies.
  • The role of cytokines in RM is complex, potentially mediating abortion mechanisms or contributing to thrombosis in conditions like antiphospholipid syndrome.

Purpose of the Study:

  • To review the multifaceted roles of cytokines in recurrent miscarriage.
  • To explore how cytokine dysregulation contributes to pregnancy loss in various RM etiologies.
  • To assess the potential of immunomodulation and hormonal support in managing RM.

Main Methods:

  • Literature review examining the involvement of cytokines in implantation, trophoblast immunosurveillance, and apoptosis.

Related Experiment Videos

  • Analysis of cytokine involvement in specific RM causes, including antiphospholipid syndrome and teratogenesis.
  • Evaluation of existing therapeutic strategies such as immunomodulation and hormonal support.

    • Main Results:

    • Cytokines like TNF-alpha and IL-6 may contribute to thrombosis in antiphospholipid syndrome, while NK cell activation by TNF-alpha can induce trophoblast apoptosis, inhibited by TGF-beta.
    • Structural anomalies in embryos, even with normal karyotypes, can lead to missed abortion, with teratogens inducing apoptosis via cytokines.
    • GM-CSF has shown potential in preventing teratogenesis in animal models.
    • While immunomodulation and hormonal support aim to rebalance cytokines, their efficacy in improving live birth rates in RM remains unproven.

    Conclusions:

    • Cytokines are integral to pregnancy maintenance and loss, with specific roles in RM pathogenesis.
    • Understanding the cytokine milieu is essential for assessing the pathogenicity of maternal factors and guiding treatment.
    • Further research, particularly in trials involving karyotypically normal embryos, is needed to clarify the therapeutic potential of cytokine modulation and hormonal support in RM.